Serodus ASA
http://www.serodus.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Serodus ASA
Pipeline Watch: Phase III Starts In MS, Hyperkalemia And Short Stature
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
Science Matters: CD47 Pathway Links To CV Disease, New Drug Development Opportunities
Initial research about inhibiting CD47 signaling on tumor cells has meant a focus on oncology drug development. New research shows that inhibiting this cell surface molecule could be used to treat atherosclerosis.
Norway’s Pre Diagnostics Has Alzheimer’s Test In Its Sights
Pre Diagnostics AS is a 2.5-year-old Oslo company developing a blood-based test performed by a GP and sent to a lab for early Alzheimer’s diagnosis.
Start-Up Previews, June 2012
This Month's Profile Group, Atrial Fibrillation Agents: Better Drugs For The Arrhythmic Heart, features profiles of Acesion Pharma, ChanRx, Milestone Pharmaceuticals and Serodus. Plus these Start-Ups Across Health Care: Loma Vista Medical, Ra Pharmaceuticals and Solx.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Phlogo ApS
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice